Operator of a drug research and development company designed to provide treatment for cancer. The company's platform provides re-profiling drugs for treating additional forms of cancer, enabling cancer patients to begin their treatment and get a successful treatment for cancer.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Early Stage VC | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Sven Mårten Fryknäs | Co-Founder & Chief Executive Officer |
Name | Representing | Role | Since |
---|---|---|---|
Angelica Loskog | Nxt2b | Chairman | 000 0000 |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Nxt2b | Venture Capital | Minority | 000 0000 | 000000 0 |